3'-DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS

3-脱氧核苷类似物作为潜在的抗病毒剂

基本信息

  • 批准号:
    3144251
  • 负责人:
  • 金额:
    $ 12.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-03-01 至 1993-02-28
  • 项目状态:
    已结题

项目摘要

This investigation has as its goal the design and synthesis of a series of 3'-deoxy pyrimidine and purine nucleoside analogs, and some of their nucleotide addition, the 2', 3'-unsaturated, 2', 3'-dideoxy-ara-C derivatives of 3-deazacytidine will be synthesized and evaluated as potential anti-HIV and anti-CMV agents. The approaches to be employed include the development of methodology mass spectrum, and other spectroscopic techniques, and the determination of their biological and biochemical effects. Recently, a lead compound, 1-(3-deoxy-B-D-threopentofuranosyl) cytosine (3'-deoxy-ara-C), has been synthesized and evaluated for its antiviral activity in this laboratory. Our preliminary studies have shown that 3'- deoxy-ara-C not only has potent anti-HCMV activity (ED50 = 0.31 ug/mL vs ED50 = 0.92 ug/mL for DHPG), but also is structurally different from DHPG. Based on these findings, the 5'-mono- and triphosphates of 3'-deoxy-ara-C will be prepared for biochemical studies. The understanding of the mechanism of action of 3'-deoxy-ara-C may lead to the design and synthesis of new antiviral agents with a better therapeutic index.
本研究的目标是设计和合成一系列的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAI-SHUN LIN其他文献

TAI-SHUN LIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAI-SHUN LIN', 18)}}的其他基金

3'-DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
3-脱氧核苷类似物作为潜在的抗病毒剂
  • 批准号:
    3144252
  • 财政年份:
    1990
  • 资助金额:
    $ 12.54万
  • 项目类别:
DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
脱氧核苷类似物作为潜在的抗病毒剂
  • 批准号:
    3144250
  • 财政年份:
    1990
  • 资助金额:
    $ 12.54万
  • 项目类别:
3'-DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
3-脱氧核苷类似物作为潜在的抗病毒剂
  • 批准号:
    3144249
  • 财政年份:
    1990
  • 资助金额:
    $ 12.54万
  • 项目类别:
DEOXY NUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
脱氧核苷类似物作为潜在的抗病毒剂
  • 批准号:
    2064982
  • 财政年份:
    1990
  • 资助金额:
    $ 12.54万
  • 项目类别:
NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
作为抗癌剂和抗病毒剂的新型核苷
  • 批准号:
    3188511
  • 财政年份:
    1987
  • 资助金额:
    $ 12.54万
  • 项目类别:
NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
作为抗癌剂和抗病毒剂的新型核苷
  • 批准号:
    3188510
  • 财政年份:
    1987
  • 资助金额:
    $ 12.54万
  • 项目类别:
NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
作为抗癌剂和抗病毒剂的新型核苷
  • 批准号:
    3188507
  • 财政年份:
    1987
  • 资助金额:
    $ 12.54万
  • 项目类别:

相似海外基金

ACTG 303--RISK STATUS FOR DISEASE PROGRESSION AND RESPONSE TO ANTIAIDS AGENT
ACTG 303--疾病进展的风险状态和抗艾滋病药物的反应
  • 批准号:
    6114298
  • 财政年份:
    1998
  • 资助金额:
    $ 12.54万
  • 项目类别:
ACTG 303--RISK STATUS FOR DISEASE PROGRESSION AND RESPONSE TO ANTIAIDS AGENT
ACTG 303--疾病进展的风险状态和抗艾滋病药物的反应
  • 批准号:
    6275533
  • 财政年份:
    1997
  • 资助金额:
    $ 12.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了